As reported in January 2014 in the Annals of the Rheumatic Diseases, a study by the University of Sydney titled “Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial” demonstrated that a supplement of “glucosamine–chondroitin resulted in a statistically significant (p=0.046) reduction of 2-year JSN compared to placebo”, with a “mean difference 0.10 mm (95% CI 0.002 mm to 0.20 mm)”.
These primary ingredients are the same as found in S·ONE·S G Plus, and are further combined with a 5 gram dose of hydrolyzed collagen. The new study further supports the value of collagen, glucosamine and chondroitin as effective supplements for joint pain improvement.
To read more, click here.